Answers are grounded in this paper and cite their sources.
Our results illustrate that a wide-range of mutations can modulate the activity of many cellular resistance processes and demonstrate that E. coli has a large mutational target size for increasing antibiotic tolerance. Furthermore, the work suggests that clinical levels of antibiotic resistance might develop through the sequential accumulation of chromosomal mutations of small individual effect.
No takes yet. Share an insight, caveat, or question.
Girgis et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: